Class IITerminatedD-0083-2018
Drug recall · November 29, 2017
TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL recall
Why: CGMP Deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601
- Lots / codes
Lot #: 2101152; Exp. 12/11/2017 Lot #: 2101195; Exp. 04/26/2019
- Quantity
- 12 devices
- Company
- United Therapeutics Corp., Durham, NC
- Distribution
- PA
- Initiated
- September 11, 2017 · Voluntary: Firm initiated
- Classified
- November 19, 2017
- Reported
- November 29, 2017
- Ended
- April 3, 2019
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.